Home › All Companies › AVTR

Avantor, Inc. (AVTR)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-04-29

Key Insights

  • Avantor announced Q1 2026 financial results on April 29, 2026, indicating operational performance for the quarter ended March 31, 2026, though specific financial metrics are not disclosed in the 8-K body itself.
  • The filing is a standard earnings announcement with minimal material detail provided in the 8-K form, with the substantive financial information contained in the attached press release (Exhibit 99.1).
  • Signed by Steven Eck, Senior Vice President and Chief Accounting Officer, indicating normal financial reporting procedures with no executive or leadership changes evident from this filing.
Sentiment: Neutral Significance: 2/10
View Original Filing →
Quarterly Report Filed: 2026-04-29

Key Insights

  • The filing shows Avantor operates through two primary segments: Bioscience Medtech Products and VWR Distribution Services, with multiple debt instruments including senior notes and term loans maturing between 2024-2032, indicating a structured but leveraged capital structure.
  • The company has accumulated other comprehensive income adjustments and translation differences across quarters, suggesting exposure to foreign exchange volatility and potential hedging activities that impact reported earnings.
  • Environmental liabilities are disclosed for operations in New Jersey and Poland with minimum/maximum ranges noted, which could represent material contingent obligations requiring monitoring for potential financial impact.
  • The presence of capital lease obligations and multiple credit facilities (revolving credit amended to mature October 2030, term loans maturing October 2030 and 2032) indicates active management of working capital and debt refinancing needs in the near to medium term.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Insider Trading Filed: 2026-04-06

Key Insights

  • Steven Eck, SVP and Chief Accounting Officer of Avantor, Inc., acquired 31,645 shares of the company's common stock through a grant of restricted stock units.
  • The restricted stock units vest in three equal annual installments starting on April 3, 2027, indicating Eck's long-term commitment to the company.
  • Insider buying, such as this acquisition, can be a positive signal for investors as it suggests management's confidence in the company's future performance.
Sentiment: Positive Significance: 6/10
View Original Filing →
Current Report Filed: 2026-04-01

Key Insights

  • Avantor's CFO, Mr. R. Brent Jones, has resigned to join a company outside the life sciences industry. This leadership change may introduce uncertainty in the near term.
  • The company has appointed Steven Eck, the current Senior Vice President and Chief Accounting Officer, as the interim CFO while it undertakes a search for a permanent replacement.
  • To compensate Mr. Eck for the additional responsibilities as interim CFO, the company has provided him with a monthly payment and a one-time restricted stock unit award, aligning his interests with shareholders.
Sentiment: Neutral Significance: 5/10
View Original Filing →
Insider Trading Filed: 2026-02-25

Key Insights

  • The reporting person, Steven W. Eck, who is the SVP and Chief Accounting Officer of Avantor, Inc. (AVTR), has disposed of 2,469 shares of the company's common stock through share withholding to cover tax obligations.
  • The transactions occurred on February 23, 2026 and February 24, 2026, at prices of $8.89 and $9.11, respectively.
  • Following the reported transactions, the reporting person still holds 99,333 shares of Avantor's common stock, indicating continued ownership and commitment to the company.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Insider Trading Filed: 2026-02-25

Key Insights

  • Benoit Gourdier, the EVP of Bioscience & Medtech at Avantor, Inc. (AVTR), disposed of 3,029 shares of common stock on February 23, 2026, through a tax withholding transaction.
  • Following the reported transaction, Gourdier still holds 362,859 shares of Avantor's common stock, indicating he maintains a significant ownership position in the company.
  • This insider transaction provides insight into Avantor's executive compensation and equity incentive programs, as well as Gourdier's ongoing commitment to the company.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Insider Trading Filed: 2026-02-25

Key Insights

  • The reporting person, R. Brent Jones, who is the Executive Vice President and Chief Financial Officer of Avantor, Inc. (AVTR), disposed of 2,805 shares of the company's common stock on February 23, 2026.
  • The shares were disposed of through a 'F' transaction, which typically indicates the shares were withheld by the company to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
  • Following the transaction, the reporting person beneficially owns 419,782 shares of Avantor's common stock, representing their direct ownership in the company.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Insider Trading Filed: 2026-02-25

Key Insights

  • Brittany Hankamer, EVP and Chief HR Officer, sold 1,683 shares of Avantor, Inc. (AVTR) on February 23 and 24, 2026, likely for tax withholding purposes.
  • Hankamer's ownership decreased by 0.14% to 249,045 shares following the reported transactions.
  • The transactions appear routine and do not suggest any significant change in Hankamer's overall position or sentiment towards the company.
Sentiment: Neutral Significance: 3/10
View Original Filing →
Insider Trading Filed: 2026-02-25

Key Insights

  • Insider Claudius Sokenu, the EVP and Chief Legal & Compliance Officer, disposed of 2,376 shares of Avantor, Inc. (AVTR) common stock on February 23, 2026.
  • The shares were disposed of via a 'F' transaction, meaning they were withheld by the company to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
  • Following the transaction, Sokenu continues to beneficially own 252,429 shares of Avantor's common stock.
Sentiment: Neutral Significance: 4/10
View Original Filing →
Insider Trading Filed: 2026-02-12

Key Insights

  • Gregory L. Summe, a director of Avantor, Inc., has acquired an additional 100,000 shares of the company's common stock at $9.4 per share, increasing his beneficial ownership to 400,000 shares.
  • The reported transaction represents an increase in Summe's direct ownership of Avantor shares, potentially signaling his confidence in the company's future performance.
  • Insider buying activity, especially by a director, can be seen as a positive signal to investors, as it suggests the insider believes the stock is undervalued and has potential for future growth.
Sentiment: Positive Significance: 6/10
View Original Filing →
Annual Report Filed: 2026-02-11

Key Insights

  • Avantor's revenue and profitability have grown steadily over the past 3 years, indicating strong operational performance.
  • The company has made strategic investments in its Laboratory Solutions and Bioscience Production segments, which account for the majority of its revenue and growth.
  • Avantor faces potential risks from customer concentration, unionized employee concentration, and rising costs of materials and services, which could impact its future financial results.
Sentiment: Positive Significance: 7/10
View Original Filing →
Current Report Filed: 2026-02-11

Key Insights

  • Avantor, Inc. announced a realignment of its reportable business segments, consolidating into two new segments: VWR Distribution & Services and Bioscience & Medtech Products, effective in Q1 2026.
  • The company provided unaudited supplemental recast financial information for fiscal years 2023-2025 to assist investors in understanding the effects of the segment reporting changes on its historical results.
  • Avantor reported its Q4 2025 and full-year 2025 financial results, which will be discussed on a conference call with investors on February 11, 2026.
Sentiment: Neutral Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-01-12

Key Insights

  • The reporting person, Simon Dingemans, acquired 6,225 shares of Avantor, Inc. (AVTR) common stock through a restricted stock unit grant that vests on May 6, 2026.
  • This insider purchase suggests the reporting person is bullish on the company's future performance and aligns their interests with those of shareholders.
  • The timing of the transaction, occurring at the start of 2026, may indicate the reporting person's confidence in Avantor's near-term prospects.
Sentiment: Positive Significance: 6/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.